Get the Stockscreener App
125.70
4.16%
-5.46
Abivax Adr stock is traded at $125.70, with a volume of 949.67K.
It is down -4.16% in the last 24 hours and up +35.88% over the past month.
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.
See More
Previous Close:
$131.16
Open:
$133.15
24h Volume:
949.67K
Relative Volume:
0.50
Market Cap:
$10.96B
Revenue:
-
Net Income/Loss:
$-386.19M
P/E Ratio:
-23.92
EPS:
-5.2547
Net Cash Flow:
$-206.27M
1W Performance:
-8.01%
1M Performance:
+35.88%
6M Performance:
+2.93%
1Y Performance:
+80.19%
1-Day Range:
$125.68
$133.23
1-Week Range:
$125.68
$138.32
52-Week Range:
$65.67
$148.83
Abivax Adr Stock (ABVX) Company Profile
Compare ABVX vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABVX
Abivax Adr
|
125.70 | 10.96B | 0 | -386.19M | -206.27M | -5.2547 |
VRTX
Vertex Pharmaceuticals Inc
|
477.36 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
656.01 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
918.22 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.23 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
271.77 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Abivax Adr Stock (ABVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-16-26 | Initiated | Jefferies | Buy |
| Feb-24-26 | Initiated | Wedbush | Outperform |
| Nov-24-25 | Initiated | Truist | Buy |
| Nov-06-25 | Initiated | Wolfe Research | Outperform |
| Oct-13-25 | Initiated | Barclays | Overweight |
| Jul-23-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-20-25 | Initiated | Morgan Stanley | Equal-Weight |
| Dec-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jul-29-24 | Initiated | Laidlaw | Buy |
| May-20-24 | Initiated | BTIG Research | Buy |
| Apr-29-24 | Initiated | Guggenheim | Buy |
| Apr-29-24 | Initiated | Piper Sandler | Overweight |
| Nov-14-23 | Initiated | Leerink Partners | Outperform |
| Nov-14-23 | Initiated | Morgan Stanley | Equal-Weight |
View All
Abivax Adr Stock (ABVX) Latest News
ABIVAX Société Anonyme (ABVX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Caxton Associates LLP Acquires Shares of 24,750 Abivax SA Sponsored ADR $ABVX - MarketBeat
Affinity Asset Advisors LLC Has $45.10 Million Stake in Abivax SA Sponsored ADR $ABVX - MarketBeat
ABIVAX Société Anonyme (ABVX) stock price, news, quote and history - Yahoo Finance UK
Abivax SA Sponsored ADR $ABVX Position Increased by PSquared Asset Management AG - MarketBeat
Atika Capital Management LLC Sells 26,200 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat
17,000 Shares in Abivax SA Sponsored ADR $ABVX Bought by Militia Capital Management LLC - MarketBeat
ETFs Investing in Abivax SA Sponsored ADR Stocks - TradingView
Abivax SA Sponsored ADR $ABVX Shares Bought by Jennison Associates LLC - MarketBeat
Principal Financial Group Inc. Increases Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
Brummer Multi Strategy AB Boosts Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Diversify Wealth Management LLC Purchases 14,626 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat
Should you buy Abivax SA sponsored ADR (ABVX) after golden cross? - MSN
Candriam S.C.A. Takes $4.01 Million Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Should You Buy Abivax SA Sponsored ADR (ABVX) After Golden Cross? - Yahoo Finance
3 Soaring Stocks That May Have More Upside Ahead - The Motley Fool
2X10 Forecast — Price Target — Prediction for 2027 - TradingView
symbol__ Stock Quote Price and Forecast - CNN
Why Abivax’s Hot Rally Is Suddenly Cooling Off - TipRanks
Weekly Recap: Upsized $920M ADS offering and Obefazimod UC results - TradingView
Pictet Asset Management Holding SA Reduces Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Analysts Offer Insights on Healthcare Companies: SCYNEXIS (SCYX) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
Abivax SA Raises $760 Million in Major U.S. ADS Offering - TipRanks
Abivax Slides As Massive Stock Offering Spooks Traders - TipRanks
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Why is Abivax stock climbing today? - Investing.com UK
Abivax stock surges on Phase 3 ulcerative colitis data By Investing.com - Investing.com Nigeria
Abivax Posts Positive Phase 3 Maintenance Data for Obefazimod in Refractory Ulcerative Colitis - TipRanks
Abivax Stock Slides as Phase 3 Update Disappoints - TipRanks
Abivax stock surges on Phase 3 ulcerative colitis data - Investing.com
A3EWCP Forecast — Price Target — Prediction for 2027 - TradingView
Abivax SA sponsored ADR (ABVX) loses 41.4% in 4 weeks, here's why a trend reversal may be around the corner - MSN
Abivax SA Sponsored ADR Actuals & Estimates (NASDAQ:ABVX) - TradingView
The Nasdaq Biotechnology Index closed up more than 1.52%. Among its constituents, Absci surged 35.96%, Silence Therapeutics rose 26.00%, and Aardvark Therapeutics, Definium Therapeutics, Black Diamond, Personalis, and Adaptive Biotechnologies gai - Bitget
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Icon (ICLR) and Liquidia Technologies (LQDA) - The Globe and Mail
ABVX News | ABIVAX SA-ADR (NASDAQ:ABVX) - ChartMill
Abivax Soars As New Crohn’s Trial Ignites Hopes - TipRanks
Abivax SA Sponsored ADR (ABVX) Gets a Buy from Guggenheim - The Globe and Mail
Barclays Keeps Their Buy Rating on Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
Why Abivax SA Sponsored ADR Stock Is Sinking - TipRanks
Why Abivax Shares Are Sinking Despite Trial Success - TipRanks
ABIVAX SA-ADR (ABVX) Stock Chart - ChartMill
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and MaxCyte (MXCT) - The Globe and Mail
Abivax Adr Stock (ABVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.46%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):